Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574420B details high-yield aminopyrrolidine synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN101407469A details a greener chlorination route for Bupropion HCl, replacing bromine to lower costs and environmental impact for pharmaceutical manufacturing.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Patent CN106916857B reveals a three-enzyme system for high-purity L-glufosinate-ammonium. This breakthrough enables significant cost reduction and supply chain reliability.
Patent CN103014081A details a green enzymatic route for 3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate, offering superior chirality and cost reduction in pharmaceutical intermediate manufacturing.
Novel enzymatic route for (S,S)-2,8-diazabicyclo[4,3,0]nonane. Reduces steps, avoids high-pressure hydrogenation. Reliable pharma intermediate supplier.
Patent CN111689881A reveals a catalytic sulfonation method for 4-chloro-2-fluoro-5-sulfamoylbenzoic acid, offering high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN108178761A reveals a mild PtO2 catalytic route for Sitagliptin. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111689933B details a green one-pot reductive amination using biomass-derived HMF and nitrobenzene, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN112028814B details a novel Cu/DMAP catalyzed method for amine synthesis, offering cost-effective routes for pharmaceutical intermediates.
Patent CN101270058B details a high-yield hydrogenation route for 3-(1-dimethylaminoethyl)phenol, offering superior purity and cost efficiency for Alzheimer's drug intermediates.
Patent CN104277018B enables high-purity 2 5-dimethylaminofuran production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112479968A reveals a room-temperature hydroamination route using KI/KHSO4, offering a cost-effective alternative to transition metals for pharmaceutical intermediates.
Novel enzymatic synthesis route ensures high purity and yield for HIV integrase inhibitor intermediates, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN110156608B reveals a novel catalytic route for p-chlorophenethylamine, offering safer processing and high purity for reliable pharmaceutical intermediate suppliers.
Patent CN105646261A reveals a streamlined tetracaine preparation method enhancing yield and reducing steps for reliable pharmaceutical intermediates supplier operations.
Patent CN112209837A reveals a novel reductive amination route for Butenafine HCl, offering superior purity and cost reduction in API manufacturing compared to traditional chloromethylation methods.
Patent CN109824539B details a novel 6-step Tigecycline synthesis from Demethyl Aureomycin, offering high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Advanced catalytic method for high-purity 1-amino-2,3-propanediol synthesis. Reduces by-products and enhances supply chain reliability for iohexol intermediates.
Novel catalytic amination process for ethacridine reduces waste and improves purity. Ideal for pharmaceutical supply chains seeking cost-effective API manufacturing solutions.